{"name":"Jianwu Dai","slug":"jianwu-dai","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5makpqTkhYdVV1NHVZV2JfR3VEZVByNEtCVHU2V3VvVmEyTnc2WUZwOFhiUHFGbXdSXy01RVppZG9uNXJUR3VJaF9KcmRxb29EZXhCcW9JQ0hNY3pMX25J?oc=5","date":"2024-07-27","type":"pipeline","source":"Nature","summary":"Heterogeneous fibroblasts contribute to fibrotic scar formation after spinal cord injury in mice and monkeys - Nature","headline":"Heterogeneous fibroblasts contribute to fibrotic scar formation after spinal cord injury in mice and monkeys","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1vN1NkM0J4WnVlX3ZyTW44RHJHUWQ4TW5ZZ0NlaE9FbDBWZWJ4NTJSejlISy1tTWhnSlV0SWZPeWpmcFpOcUpFRENIUU1ZN1RlYUlTcHZjVmRtOTVhTDQ0?oc=5","date":"2023-02-08","type":"pipeline","source":"Science | AAAS","summary":"Spinal cord tissue engineering via covalent interaction between biomaterials and cells - Science | AAAS","headline":"Spinal cord tissue engineering via covalent interaction between biomaterials and cells - Science | AAAS","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}